⌘K

Home/Filings/4/0001209191-21-010204

4//SEC Filing

Chen Hubert C 4

Accession 0001209191-21-010204

CIK 0001634379other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:01 PM ET

Size

5.4 KB

Accession

0001209191-21-010204

Insider Transaction Report

Form 4

Period: 2021-02-10

Metacrine, Inc.MTCR

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2021-02-10+90,000→ 90,000 total
Exercise: $10.09Exp: 2031-02-09→ Common Stock (90,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the option shall vest on the one year anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter until fully vested on February 10, 2025.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Metacrine, Inc.

CIK 0001634379

Entity typeother

Related Parties

1

filerCIK 0001622297

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 5:01 PM ET
Size: 5.4 KB

View on SEC.gov